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Abstract
Introduction: Thyroid nodular goitre is one of the most common endocrine disorders. Differentiating between benign and malignant 
lesions is an emerging challenge in endocrinological practice. Ultrasonography (US) remains the most commonly applied method in the 
preliminary assessment of lesions and is the basis for the decision as to fine needle aspiration biopsy (FNAB) and further diagnostics. 
Many studies have evaluated the diagnostic value of US malignancy features. However, they focused mainly on papillary thyroid cancer 
(PTC). It remains unclear whether other types of thyroid carcinoma (TC) are also characterised by the same US features. The aim of this 
study was to assess the usefulness of US features considered as markers in the diagnosis of medullary thyroid cancer (MTC).
Material and methods: The PubMed/MEDLINE and Cochrane Library databases were searched to identify studies on US features of 
MTCs. The random-effects model was used to calculate pooled sensitivity and specificity and odds ratios (OR) — if a comparison with 
PTCs was available. 
Results: Hypoechogenicity was present in 83.4% of MTCs, and 32.7% were markedly hypoechogenic. None of the 157 MTCs was hyper-
echogenic. Sensitivity of halo absence was 88.9%, but irregular margins were present in 38.0%. 35.5% of MTCs had microcalcifications, 
and 27.0% had macrocalcifications. 14.4% presented ‘taller than wide feature’ (higher anteroposterior than transverse diameter). Apart 
from macrocalcifications, all these features occurred insignificantly less often in MTCs than in PTCs.
Conclusions: US features commonly considered as markers of malignancy can be useful also in the diagnostics of MTCs. However, MTCs 
tend to possess suspicious US features slightly less often than PTCs. Some features, such as hyperechogenicity, can be considered to be 
strong markers of benign status. Although the US appearance of the thyroid lesion is an important diagnostic factor, it is worth remem-
bering that it does not allow for a definitive differentiation between benign and malignant nodules. In the case of MTCs, as well as other 
TCs, US examination remains a valuable diagnostic tool, but should always be interpreted carefully in the context of other examinations. 
(Endokrynol Pol 2014; 65 (4): 314–318)
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Streszczenie
Wstęp: Guzki tarczycy należą do najczęstszych zaburzeń spotykanych w endokrynologii. Różnicowanie zmian łagodnych i złośliwych 
stanowi wyzwanie w praktyce endokrynologicznej. Badanie ultrasonograficzne (USG) pozostaje najczęściej stosowaną metodą wstępnej 
oceny zmian, a także podstawą dla decyzji o biopsji cienkoigłowej i dalszej diagnostyce. W licznych pracach oceniano wartość diagnostyczną 
cech sonograficznych uważanych za markery złośliwości. Były one jednak skupione głównie na rakach brodawkowatych tarczycy (RBT). 
Przedmiotem kontrowersji pozostaje, czy inne typy raków tarczycy charakteryzują się tymi samymi cechami sonograficznymi. Celem pracy 
było określenie użyteczności cech sonograficznych uznawanych za markery złośliwości w diagnostyce raków rdzeniastych tarczycy (RRT).
Materialy i metody: Przeszukano bazy danych Pubmed/MEDLINE oraz Cochrane Library w celu odnalezienia prac zawierających dane 
o cechach sonograficznych raków rdzeniastych. Model efektów zmiennych został użyty do obliczenia czułości, swoistości oraz ilorazów 
szans — gdy dostępne były również dane dotyczące raków brodawkowatych. 
Wyniki: Hipoechogenność była obecna w 83,4% przypadków raków rdzeniastych, 32,7% RRT wykazywało głęboką hipoechogenność. 
Żaden ze 157 RRT nie był hiperechogenny. Czułość braku “halo” wynosiła 88,9%, jednak nierówne granice były obecne jedynie w 32,7% 
przypadków. 35,5% RRT posiadało mikrozwapnienia, 27,0% — makrozwapnienia. 14,4% RRT posiadało cechę “taller than wide” (przewaga 
wymiaru przednio — tylnego nad poprzecznym). Za wyjątkiem makrozwapnień, wszystkie wymienione cechy występowały nieistotnie 
statystycznie rzadziej w RRT niż RBT.
Wnioski: Cechy sonograficzne uważane za markery złośliwości są przydatne również w diagnostyce raków rdzeniastych tarczycy. Jed-
nakże w przypadku RRT występują one nieco rzadziej niż w przypadku RBT. Niektóre cechy, jak hiperechogenność, można uznać za 
przemawiające silnie za nieobecnością RRT. Jakkolwiek obraz sonograficzny zmian ogniskowych w tarczycy stanowi wartościowy element 
diagnostyczny należy pamiętać, że nie pozwala on na definitywne rozstrzygnięcie charakteru zmiany. W przypadku raków rdzeniastych, 
podobnie jak innych typów raka tarczycy, USG pozostaje wartościowym narzędziem, jego wynik powinien być jednak interpretowany 
ostrożnie, z uwzględnieniem wyników innych badań. (Endokrynol Pol 2014; 65 (4): 314–318)
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Introduction
Thyroid nodular goitre is one of the most common 
endocrine disorders [1,2]. Differentiating between be-
nign and malignant lesions is an emerging challenge 
in endocrine practice. Ultrasonography (US) remains 
the most commonly applied method in the preliminary 
assessment of lesions and forms the basis for the deci-
sion as to fine needle aspiration biopsy (FNAB) and 
further diagnostics.
Numerous studies have evaluated the diagnostic 
value of sonographic malignancy features. However, 
they have focused mainly on papillary thyroid cancer 
(PTC) as the most frequent thyroid malignancy [3–5]. 
The controversial issue is whether other types of thy-
roid carcinoma (TC), such as medullary thyroid cancer 
(MTC), are also characterised by the same US features.
MTC accounts for 3.5–10% of all TCs [6]. It derives 
from the parafollicular C-cells, which produce the hor-
mone calcitonin. About 75% of MTCs are sporadic and 
25% are hereditary cases [7]. This tumour is usually dif-
ficult to diagnose, and consequently 35% of patients at 
the time of diagnosis have MTC extending beyond the 
thyroid [8]. Routine measurement of calcitonin level is 
not commonly used in diagnosing patients with thyroid 
nodules because of the high cost [9]. Thus there arises 
a question about the US appearance of MTCs which is 
crucial in the initial steps of diagnostics. 
The aim of this study was to assess the usefulness 
of ultrasound features considered to be markers of ma-
lignancy in the diagnosis of medullary thyroid cancer.
Material and methods
Literature search and data extraction
We searched the PubMed/MEDLINE and Cochrane Li-
brary databases in order to identify all relevant research 
articles. The search terms ‘medullary thyroid cancer’ 
or ‘medullary thyroid carcinoma’ and ultrasound or 
ultrasonography or elastography or ‘power Doppler’ 
or ‘color Doppler’ were used. The following filters were 
applied — English language and publication between 
January 2000 and May 2013. The literature search was 
performed independently by two authors (K.W. and 
M.R-Ł.). All papers, including data on US, ES and 
Doppler examination features of histhopatologically 
confirmed MTCs, were included. 
Statistical analysis
Pooled sensitivities and specificities of particular mark-
ers of malignancy were calculated using a random-
effect model according to the methodology described 
by Borenstein et al. [10]. Results of studies comparing 
frequencies of particular features in MTCs and PTCs 
were combined using Statistica v. 10 from StatSoft. 
A P value under 0.05 was considered statistically signifi-
cant. Meta-analysis was performed if at least three stud-
ies provided data on a particular marker of malignancy. 
Results
Six studies containing data on sonographic features of 
169 MTCs were included into the meta-analysis (Table I). 
All these studies had a retrospective character. Three 
of them encompassed also comparisons with PTCs, 
and two with benign thyroid nodules. The steps of 
selection are shown on the flowchart (Fig. 1). Results 
of included studies on the US appearance of MTCs are 
summarised in Table II.
Hypoechogenicity
Five studies containing data on 157 MTCs provided 
data on the occurrence of hypoechogenicity. The pooled 
frequency was 83.4% (95% CI 46.5–100.0%). There was 
no evidence for significant heterogeneity (Q = 0.11, 
p = 1.0). Three studies included comparisons between 
MTCs and PTCs. Pooled OR was 0.97 (95% CI 0.64 – 1.46). 
There was no evidence for significant heterogeneity 
(Q = 0.03, p = 0.98). None of the 157 MTCs was hy-
perechogenic.
Table I. General characteristics of studies on the US features of medullary thyroid cancers
Tabela I. Ogólna charakterystyka prac o cechach sonograficznych raków rdzeniastych tarczycy
Author Year Number of MTCs Number of patients Sex Age [mean, ± standard 
deviation]
Comments
Trimboli et al. [5] 2012 12 12 7 women, 5 men 62.8 ± 15.1 Comparison with PTCs
Choi et al. [11] 2011 36 30 21 women, 9 men 48.7 ± 14.4
Cai et al. [14] 2010 35 27 14 women, 13 men 45.7 ± 12.8
Kim et al. [4] 2009 21 18 15 women, 3 men 50.4 Comparison with PTCs
Lee et al. [3] 2009 42 42 29 women, 13 men 48 Comparison with PTCs
Saller et al. [15] 2002 19 19 9 women, 10 men 46 ± 17 Comparison with 
benign nodules
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Four studies containing data on 134 MTCs provided 
data on the occurrence of marked hypoechogenicity. 
The pooled frequency was 32.7% (95% CI 21.8–49.1%). 
There was no evidence for significant heterogeneity 
(Q = 3.01, p = 0.39). Two studies included compari-
sons between MTCs and PTCs [3, 4]. Both showed 
that marked hypoechogenicity was insignificantly less 
frequent in MTCs. 
Microcalcifications
Six studies containing data on 169 MTCs provided data 
on the occurrence of microcalcifications. The pooled 
frequency was 35.5% (95% CI 25.8–49.0%). There was 
no evidence for significant heterogeneity (Q = 0.00, 
p = 1.0). Three studies included comparisons between 
MTCs and PTCs. Pooled OR was 0.64 (95% CI 0.38–1.10). 
There was no evidence for significant heterogeneity 
(Q = 4.27, p = 0.12).
Macrocalcifications
Six studies containing data on 169 MTCs provided data 
on the occurrence of macrocalcifications. The pooled 
frequency was 27.0% (95% CI 18.3–39.8%). There was 
no evidence for significant heterogeneity (Q = 3.74, 
p = 0.59). Three studies included comparisons between 
MTCs and PTCs. Pooled OR was 1.77 (95% CI 0.83–3.79). 
There was no evidence for significant heterogeneity 
(Q = 1.44, p = 0.49).
Absent or irregular halo
Three studies containing data on 66 MTCs provided 
data on the occurrence of halo irregularity or ab-
sence. The pooled frequency was 89.9% (95% CI 
31.9–100.0%). There was no evidence for significant 
heterogeneity (Q = 0.00, p = 1.00). One study in-
cluded a comparison between MTCs and PTCs [5]. 
It showed that halo absence was insignificantly less 
frequent in MTCs (p = 0.06).
Solid composition
Six studies containing data on 169 MTCs provided data 
on the occurrence of solid composition. The pooled 
frequency was 79.2% (95% CI 51.8–100.0%). There was 
no evidence for significant heterogeneity (Q = 0.25, 
p = 1.00). Three studies included comparisons between 
MTCs and PTCs. Pooled OR was 0.79 (95% CI 0.52–1.18). 
There was no evidence for significant heterogeneity 
(Q = 0.43, p = 0.80). There were no pure cystic MTCs, 
and only one predominantly cystic MTC, reported in 
the included studies.
Table II. Results of included studies on the US appearance of medullary thyroid cancers
Tabela II. Wyniki prac o cechach sonograficznych raków rdzeniastych tarczycy
  Trimboli et al. [5] Choi et al. [11] Cai et al. [14] Kim et al. [4] Lee et al. [3] Saller et al. [15]
Hypoechogenicity 6 of 8 solid; 35/36 34/35 20/21 36/42 19/19
Marked hypoechogenicity – 9/36 15/35 11/21 9/42 –
Microcalcifications 2/12 17/36* 10/35 6/21 18/42 7/19
Macrocalcifications 2/12 7/36* 13/35 5/21 8/42 11/19
Absent or irregular halo 9/12 26/36 34/35 – – 18/19
Irregular margins 0/12 17/36**   – 19/42 –
‘Taller than wide’ – 6/36 1/35 4/21 6/42 –
Solid composition 8/12 33/36 29/35 19/21 31/42 18/19
*three MTCs contained both micro and macrocalcifications; **margins defined as speculated or ill defined were included
Figure 1. Flowchart demonstrating the steps of the literature 
search
Rycina 1. Diagram pokazujący etapy selekcji prac
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Irregular margins
Four studies containing data on 114 MTCs provided 
data on the occurrence of irregular margins. The pooled 
frequency was 38.0% (95% CI 21.4–67.4%). There was 
no evidence for significant heterogeneity (Q = 3.82, 
p = 0.28). Three studies included comparisons between 
MTCs and PTCs. Pooled OR was 0.33 (95% CI 0.09–1.26). 
There was evidence for significant heterogeneity 
(Q = 6.49, p = 0.04).
‘Taller than wide’ feature
Four studies containing data on 134 MTCs provided 
data on the occurrence of ‘taller than wide’ feature. The 
pooled frequency was 14.4% (95% CI 8.6–24.2%). There 
was no evidence for significant heterogeneity (Q = 2.90, 
p = 0.41). Two studies included comparisons between 
MTCs and PTCs. Both showed that the ‘taller than wide’ 
feature was less frequent in MTCs: the result of one of 
them was on the border of statistical significance (Kim 
et al., p = 0.055), and the second achieved significance 
(Lee et al., p = 0.001) [3, 4].
Discussion
Hypoechogenicity, halo absence, and solid composition 
are the most common sonographic features of MTCs. 
Also calcifications are frequent findings in MTCs. Micro-
calcifications occurred in 35.5%, and macrocalcifications 
in a further 27.0%. Irregular margins were moderately 
common (38.0%) in MTCs; however, there was signifi-
cant heterogeneity due to the great dispersion of results 
of particular studies — from 0% [5] to nearly 50% [11]. 
Partly this could be the effect of the small number of 
studies assessing this feature. Furthermore, this at-
tribute has been described by some authors as being 
characterised by low intra- and interobserver agreement 
[12, 13]. The ‘taller than wide’ feature turned out to be 
rarely present in MTCs. 
The amount of available data on the US features of 
MTCs is low. Six included studies contained descrip-
tions of 169 MTCs. As the panels of assessed features 
were partly different in particular studies, the amount 
of information about some of the markers is even lower. 
There was not enough data on Colour Doppler (CD) 
and Power Doppler (PD) examinations to meta-analyse. 
However, a few studies contained some information 
on this topic. Trimboli et al. [5] reported that three of 
12 MTCs presented intranodular flow in CD. Accord-
ing to Cai et al. [14], seven of 29 examined cancers had 
strong intranodular flow, and 15 had moderate flow. 
Saller et al. [15] assessed the usefulness of PD: intran-
odular flow was present in six of 14 examined MTCs, 
and intranodular flow with concomitant perinodular 
signal in a further five tumours. We did not find any 
study containing information about the appearance 
of MTCs in soelastography, which is believed to be an 
important improvement on conventional US. This has 
been described as a valuable tool in differentiating be-
tween benign and malignant thyroid nodules [16, 17], 
diagnostic of other thyroid diseases, such as Graves’ 
disease, chronic or subacute thyroiditis [18–20].
Three studies compared the occurrence of these 
markers of malignancy in MTCs and PTCs, including 
data on 79 MTCs and 208 PTCs. Macrocalcifications 
were slightly more frequent in MTCs, hypoecho-
genicity occurred in fact equally often in both groups 
(OR = 0.97), and all other meta-analysed features were 
somewhat less common in MTCs. However, none of 
these differences achieved statistical significance. This 
is probably partly due to the small number of studies 
and investigated cancers. Commonly used US markers, 
apart from macrocalcifications and hypoechogenicity, 
seem to be less sensitive in the diagnostics of MTCs, 
but further studies are needed to reach a definite 
conclusion. Most studies did not compare the US ap-
pearance of sporadic and hereditary MTCs. The study 
performed by Saller et al. did not reveal significant 
differences, although it encompassed only ten patients 
with sporadic MTC, seven with MEN  2A, and two 
with MEN 2B [15].
According to our results, typical MTC appears as 
a solid, hypoechogenic (often markedly) lesion with-
out a halo and quite commonly containing micro- or 
macrocalcifications. However, the first three features 
are known to be very unspecific [21, 22], and the other 
two are less sensitive. In our opinion, the presence of 
a lesion with the appearance described above should 
arouse a suspicion of MTC and should be considered 
as an argument for further diagnostic steps, such as 
calcitonin measurement. On the other hand, most 
MTCs do not present all of the above features, and 
some of them can have a relatively benign US appear-
ance. Particularly in cases of family history of MTC, the 
absence of the abovementioned US malignancy features 
is insufficient to exclude this type of malignancy. How-
ever, some attributes can be considered as markers of 
benign status. Especially hyperechogenicity and pure 
or predominantly cystic character seem to be extremely 
uncommon in MTCs. Isoechogenicity, halo presence, 
and minor cystic components also decrease the risk 
that a particular tumour is MTC, as these features are 
present in about 10% to 20% of MTCs.
In conclusion, US features commonly considered as 
markers of malignancy can be useful also in diagnosing 
MTCs. However, MTCs tends to possess suspicious US 
features slightly less often than PTCs. Some features, 
such as hyperechogenicity, strongly decrease the risk of 
MTC. Although the US appearance of the thyroid lesion 
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is an important diagnostic factor, it is worth remember-
ing that it does not allow for a definitive differentiation 
between benign and malignant nodules. In a case of 
MTC, as well as other TCs, US examination remains a 
valuable diagnostic tool, but it should always be inter-
preted carefully in the context of other examinations.
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